Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURF-201 in Cataract Surgery
NCT04324359Phase 2Completed
- Sponsor
- Surface Ophthalmics
- Start
- Mar 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SURF-201 in ocular inflammation, post-surgical ocular pain, sponsored by Surface Ophthalmics. Started Mar 2020; status: completed.
02
Drugs
SURF-201
03
Conditions
ocular inflammationpost-surgical ocular pain
Beyond the preview
Go deeper on NCT04324359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04324359.